About Tenax Therapeutics
Tenax Therapeutics is a company based in Morrisville (United States) founded in 1967.. The company has 6 employees as of December 31, 2024. Tenax Therapeutics offers products and services including TNX-201 and TNX-103. Tenax Therapeutics operates in a competitive market with competitors including Actelion, AskBio, Juvenescence, Inotrem and Aerovate Therapeutics, among others.
- Headquarter Morrisville, United States
- Employees 6 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tenax Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-17.6 M-128.28as on Dec 31, 2024
-
EBITDA
$-19.49 M-136.97as on Dec 31, 2024
-
Latest Funding Round
$25 M (USD), Post-IPO
Mar 05, 2025
-
Investors
RTW Investments
& 1 more
-
Employee Count
6
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tenax Therapeutics
Tenax Therapeutics is a publicly listed company on the NASDAQ with ticker symbol TENX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Tenax Therapeutics
Tenax Therapeutics offers a comprehensive portfolio of products and services, including TNX-201 and TNX-103. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral enteric coated imatinib for pulmonary hypertension treatment.
Oral levosimendan for cardiopulmonary condition therapies.
Unlock access to complete
Unlock access to complete
Leadership Team
8 people
Scientific Team
7 people
Finance and Accounting
2 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Tenax Therapeutics
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $25.0M
-
First Round
First Round
(08 Jun 2009)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Post-IPO - Tenax Therapeutics | Valuation |
investors |
|
| Aug, 2024 | Amount | Post-IPO - Tenax Therapeutics | Valuation |
investors |
|
| May, 2022 | Amount | Post-IPO - Tenax Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tenax Therapeutics
Tenax Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include RTW Investments and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tenax Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tenax Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tenax Therapeutics Comparisons
Competitors of Tenax Therapeutics
Tenax Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Actelion, AskBio, Juvenescence, Inotrem and Aerovate Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovative treatments for orphan diseases are discovered, developed, and commercialized.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health
|
|
| domain | founded_year | HQ Location |
Developer of peptide immunotherapies for treating septic shock and acute myocardial infarction
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for pulmonary arterial hypertension are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs that target deubiquitylating enzymes involved in the DNA damage response
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tenax Therapeutics
Frequently Asked Questions about Tenax Therapeutics
When was Tenax Therapeutics founded?
Tenax Therapeutics was founded in 1967 and raised its 1st funding round 42 years after it was founded.
Where is Tenax Therapeutics located?
Tenax Therapeutics is headquartered in Morrisville, United States.
How many employees does Tenax Therapeutics have?
As of Dec 31, 2024, the latest employee count at Tenax Therapeutics is 6.
What does Tenax Therapeutics do?
Developer of therapeutics to address cardiovascular and pulmonary diseases. The companys pipeline include levosimendan is calcium sensitizer that is approved ex-US for acute decompensated heart failure in cardiac surgery patients and Oxycyte is a PFC-based oil in water emulsion that is given intravenously to patients in order to facilitate oxygen transportation from the lungs.
Who are the top competitors of Tenax Therapeutics?
Tenax Therapeutics's top competitors include Juvenescence, AskBio and Mission Therapeutics.
What products or services does Tenax Therapeutics offer?
Tenax Therapeutics offers TNX-201 and TNX-103.
Is Tenax Therapeutics publicly traded?
Yes, Tenax Therapeutics is publicly traded on NASDAQ under the ticker symbol TENX.
Who are Tenax Therapeutics's investors?
Tenax Therapeutics has 2 investors. Key investors include RTW Investments, and Military Health.
What is Tenax Therapeutics's ticker symbol?
The ticker symbol of Tenax Therapeutics is TENX on NASDAQ.